Browsing by Subject "ZFN"
Now showing items 1-1 of 1
-
Gene editing-based technologies for beta-hemoglobinopathies treatment
(MDPI, 2022)Simple Summary: β-thalassemia syndromes are clinically and genetically heterogeneous blood disorders presented by β-chain deficiency in hemoglobin production. Despite improvements in transfusion practices and chelation ...